Locoid cream 1mg/g 30g — Made in Italy — Free Delivery

Locoid cream is used in conditions when there is a response to treatment with corticosteroids (eczema, dermatitis, psoriasis). Topical corticosteroids are generally not indicated for the treatment of psoriasis, but may be acceptable, with the exception of common plaque psoriasis, provided precautions are taken.

The active ingredient is hydrocortisone 17-butyrate (1 g of cream contains 1 mg of hydrocortisone 17-butyrate).

Excipients: cetostearyl alcohol, macrogol cetostearyl ether, mineral light oil, white soft paraffin, propyl parahydroxybenzoate (E 216), butyl parahydroxybenzoate, anhydrous citric acid, sodium citrate, purified water.

Except in cases of treatment in combination with appropriate chemotherapeutic agents:

For cutaneous use.

Apply the preparation in a small amount with a thin even layer to the affected areas no more than 2 times a day.

May be applied under an occlusive dressing for more persistent lesions such as thickened psoriatic plaques on the elbows and knees (excluding oozing lesions).

The total course dose should not exceed 30-60 g of cream per week.

The same doses are used in adults and elderly patients, since there is no clinical evidence indicating that elderly patients need a special dosing regimen.

Data on the use of hydrocortisone butyrate in pregnant women are lacking or limited. The results of studies on laboratory animals indicate the reproductive toxicity of the preparation. Corticosteroids cross the placenta. With the systemic use of large doses of corticosteroids, the effect on the fetus or newborn child (fetal growth retardation, adrenocortical suppression) has been reported. Despite the small amount of information on the use of corticosteroids on the skin of pregnant women, given the limited systemic absorption of preparations in this group, it is possible to use corticosteroids of weak and moderate action (class 1 and class 2), such as hydrocortisone, for short periods of time and on limited skin areas ... The aforementioned effects cannot be ruled out with prolonged use or when applied to large areas of the skin. This can only be done with special indications.

Hydrocortisone butyrate / metabolites pass into breast milk, however, when using the preparation in therapeutic doses, exposure to newborns / breastfed infants is not expected. The preparation can be used by women during lactation only under conditions of short-term treatment and application to small areas of the skin. With long-term treatment or application to large areas of affected skin, breastfeeding should be discontinued.